memantine has been researched along with Hallucinations in 11 studies
Hallucinations: Subjectively experienced sensations in the absence of an appropriate stimulus, but which are regarded by the individual as real. They may be of organic origin or associated with MENTAL DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The current retrospective analysis evaluated the efficacy and safety of memantine in a subpopulation of patients with Alzheimer's disease exhibiting behavioral symptoms of agitation/aggression or psychosis at baseline." | 9.13 | Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. ( Ballard, CG; Cooper, JA; Loft, H; Wilcock, GK, 2008) |
| "To report on a patient with Lewy body dementia who developed worsening of hallucinations with memantine withdrawal and significant improvement with reinitiation of the drug." | 8.89 | Visual hallucinations treated with the reinitiation of memantine in a patient with Lewy body dementia. ( Blaszczyk, AT; Mathys, ML; McCarrell, J; Sleeper, RB, 2013) |
| "Three patients with probable dementia with Lewy bodies (DLB) experienced worsening delusions and visual hallucinations as a result of memantine therapy." | 7.73 | Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine. ( Josephs, KA; Ridha, BH; Rossor, MN, 2005) |
| "We sought to determine whether the extended MAPT haplotype was associated with the worsening of delusions and hallucinations in a combined cohort of 95 patients who participated in 2 clinical trials of treatment with memantine." | 5.19 | Role of the extended MAPT haplotype in the worsening of psychotic symptoms and treatment response in Alzheimer disease. ( Ballard, C; Corbett, A; Creese, B; Fox, C; Jones, E, 2014) |
| " The current retrospective analysis evaluated the efficacy and safety of memantine in a subpopulation of patients with Alzheimer's disease exhibiting behavioral symptoms of agitation/aggression or psychosis at baseline." | 5.13 | Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies. ( Ballard, CG; Cooper, JA; Loft, H; Wilcock, GK, 2008) |
| "To report on a patient with Lewy body dementia who developed worsening of hallucinations with memantine withdrawal and significant improvement with reinitiation of the drug." | 4.89 | Visual hallucinations treated with the reinitiation of memantine in a patient with Lewy body dementia. ( Blaszczyk, AT; Mathys, ML; McCarrell, J; Sleeper, RB, 2013) |
| "Three patients with probable dementia with Lewy bodies (DLB) experienced worsening delusions and visual hallucinations as a result of memantine therapy." | 3.73 | Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine. ( Josephs, KA; Ridha, BH; Rossor, MN, 2005) |
| " After memantine was started he developed severe fluctuations in awareness, visual hallucinations, agitation, and worsened parkinsonism." | 3.73 | Exacerbation of Lewy bodies dementia due to memantine. ( Blazquez-Menes, B; Calatayud, MT; Menendez-Gonzalez, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Schneider, LS | 1 |
| Thornton, SL | 1 |
| Clark, RF | 1 |
| Creese, B | 1 |
| Corbett, A | 1 |
| Jones, E | 1 |
| Fox, C | 1 |
| Ballard, C | 1 |
| Clerici, F | 1 |
| Vanacore, N | 1 |
| Elia, A | 1 |
| Spila-Alegiani, S | 1 |
| Pomati, S | 1 |
| Da Cas, R | 1 |
| Raschetti, R | 1 |
| Mariani, C | 1 |
| Bute, J | 1 |
| Waller, D | 1 |
| Mathys, ML | 1 |
| McCarrell, J | 1 |
| Sleeper, RB | 1 |
| Blaszczyk, AT | 1 |
| Ridha, BH | 1 |
| Josephs, KA | 1 |
| Rossor, MN | 1 |
| Menendez-Gonzalez, M | 1 |
| Calatayud, MT | 1 |
| Blazquez-Menes, B | 1 |
| Pittenger, C | 1 |
| Naungayan, C | 1 |
| Kendell, SF | 1 |
| Coric, V | 1 |
| Malison, R | 1 |
| Krystal, JH | 1 |
| Sanacora, GS | 1 |
| Monastero, R | 1 |
| Camarda, C | 1 |
| Pipia, C | 1 |
| Camarda, R | 1 |
| Wilcock, GK | 1 |
| Ballard, CG | 1 |
| Cooper, JA | 1 |
| Loft, H | 1 |
1 review available for memantine and Hallucinations
| Article | Year |
|---|---|
Visual hallucinations treated with the reinitiation of memantine in a patient with Lewy body dementia.
Topics: Aged; Dementia; Hallucinations; Humans; Lewy Body Disease; Male; Memantine; Nootropic Agents; Treatm | 2013 |
2 trials available for memantine and Hallucinations
| Article | Year |
|---|---|
Role of the extended MAPT haplotype in the worsening of psychotic symptoms and treatment response in Alzheimer disease.
Topics: Aged; Alleles; Alzheimer Disease; Antipsychotic Agents; Delusions; Disease Progression; Excitatory A | 2014 |
Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.
Topics: Aged; Aggression; Alzheimer Disease; Delusions; Dopamine Agents; Female; Hallucinations; Humans; Mal | 2008 |
8 other studies available for memantine and Hallucinations
| Article | Year |
|---|---|
Alzheimer's and Dementia Guidelines and Tables.
Topics: Alzheimer Disease; Antipsychotic Agents; Depressive Disorder, Major; Hallucinations; Humans; Memanti | 2023 |
Encephalopathy from unintentional donepezil and memantine ingestion.
Topics: Brain Diseases; Child, Preschool; Donepezil; Electroencephalography; Female; Hallucinations; Humans; | 2014 |
Memantine effects on behaviour in moderately severe to severe Alzheimer's disease: a post-marketing surveillance study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anxiety; Apathy; Depression; Dopamine Agents; Feeding Be | 2012 |
Dementia with cardiac problems.
Topics: Adaptation, Psychological; Alzheimer Disease; Anecdotes as Topic; Arrhythmias, Cardiac; Dopamine Age | 2011 |
Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine.
Topics: Age of Onset; Aged; Antiparkinson Agents; Brain; Cognition Disorders; Disease Progression; Hallucina | 2005 |
Exacerbation of Lewy bodies dementia due to memantine.
Topics: Aged; Alzheimer Disease; Dopamine Agonists; Hallucinations; Humans; Lewy Body Disease; Male; Memanti | 2005 |
Visual hallucinations from the addition of riluzole to memantine and bupropion.
Topics: Adult; Bupropion; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Drug Interactions; Drug Th | 2006 |
Visual hallucinations and agitation in Alzheimer's disease due to memantine: report of three cases.
Topics: Aged; Alzheimer Disease; Excitatory Amino Acid Antagonists; Female; Hallucinations; Humans; Memantin | 2007 |